COMMUNIQUÉS West-GlobeNewswire

Trading in Coloplast shares by board members, executives or associated persons

01/06/2018 - 15:32

Nasdaq Copenhagen 1 June 2018 Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation art. 19 Coloplast is obliged to report on the [...]

Vistin Pharma ASA : Completion of subsequent repair issue, registration of share capital increase

01/06/2018 - 15:21

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]

Oncolytics Biotech® Prices USD $8,000,000 Million Public Offering of Common Shares

01/06/2018 - 15:13

CALGARY, Alberta and SAN DIEGO, June 01, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (TSX:ONC) (NASDAQ:ONCY), currently developing REOLYSIN ® (pelareorep), an intravenously delivered immuno-oncolytic virus [...]

Canada House Wellness Group Continues Strategic Transformation with Appointment of New Chief Executive Officer and Change to Board of Directors

01/06/2018 - 14:57

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, June 01, 2018 (GLOBE NEWSWIRE) -- The Board of Directors of Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or [...]

Lundbeck and Otsuka’s Rxulti® (brexpiprazole) receives positive opinion in EU from CHMP for the treatment of schizophrenia in adults

01/06/2018 - 14:53

Press release Valby, 1 June 2018 A final decision from the European Commission is expected within 67 days. H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announce that the Committee for [...]

CV Sciences, Inc. Settles SEC Matter

01/06/2018 - 14:45

The Company Names New Chief Executive Officer, President and Board Member LAS VEGAS, June 01, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) announced today that it [...]

SELLAS Life Sciences Provides Clinical Update on Phase 2b NeuVax™ (nelipepimut-S) Study in Combination with Trastuzumab in HER2 1+/2+ Breast Cancer Patients

01/06/2018 - 14:45

Phase 2b trial met key clinical objectives and is being discontinued early by the sponsor Clinical and regulatory meetings held at the American Society of Clinical Oncology (ASCO) conference Dr. Jeffrey S. Weber, [...]

Interpace Diagnostics Presents New Data on PancraGEN® at Digestive Disease Week

01/06/2018 - 14:30

WASHINGTON, June 01, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (the “Company” or “Interpace”), a fully integrated commercial and bioinformatics company that provides clinically useful [...]

LeMaitre Vascular to Present at the Jefferies Healthcare Conference on Friday, June 8, 2018

01/06/2018 - 14:30

BURLINGTON, Mass., June 01, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Jefferies Healthcare Conference on Friday, June [...]

Biotech with Liquid Biopsy for Colorectal Cancer Secures $26 Million in New Funding

01/06/2018 - 14:30

Clinical Genomics drives the commercialization of Colvera™, a liquid biopsy test service for colorectal cancer (CRC) recurrence and the focus of growing clinical evidence to support its use as the first widely adopted [...]

Imaging3 to Present at the 8th Annual LD Micro Invitational Conference

01/06/2018 - 14:30

BURBANK, Calif., June 01, 2018 (GLOBE NEWSWIRE) -- Imaging 3 , Inc. (OTCQB:IGNG), a development stage company introducing disruptive technologies in the medical imaging industry, has been invited to present at the 8th [...]

Maple Leaf Green World Inc. Engages Emerging Equities Inc. as its Strategic Financial Advisor in Connection and a Non-Brokered Private Placement

01/06/2018 - 14:30

CALGARY, Alberta, June 01, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) (NEO:MGW) (OTCQB:MGWFF) is pleased to announce that it has entered into an agreement with Emerging [...]

Akcea and Ionis Receive Positive EU CHMP Opinion for TEGSEDI

01/06/2018 - 14:07

CAMBRIDGE, Mass. and CARLSBAD, Calif., June 01, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), announced [...]

Novan Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01/06/2018 - 14:05

MORRISVILLE, N.C., June 01, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today reported that the Compensation Committee of Novan’s Board of Directors granted stock options to purchase an [...]

Genocea to Present at Jefferies 2018 Global Healthcare Conference

01/06/2018 - 14:04

Presentation to be webcast live at 12:30 pm ET on June 8, 2018 CAMBRIDGE, Mass., June 01, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing neoantigen cancer [...]

Novartis completes sale of stake in consumer healthcare joint venture to GSK for USD13.0 billion

01/06/2018 - 14:01

Basel, June 1, 2018 - Novartis AG ("Novartis") today announced the completion of the divestment to GlaxoSmithKline PLC ("GSK") of its 36.5 percent stake in a consumer healthcare joint venture (JV) for a total [...]

Rhythm Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference

01/06/2018 - 14:00

BOSTON, June 01, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity [...]

Kane Biotech to Showcase Technologies and Products at the 2018 BIO International Convention

01/06/2018 - 14:00

WINNIPEG, Manitoba, June 01, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased to announce that it will be attending the 2018 BIO International [...]

Spero Therapeutics to Present at the Jefferies 2018 Healthcare Conference in June

01/06/2018 - 14:00

CAMBRIDGE, Mass., June 01, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments [...]